Mexico
The pharmaceutical industry is Mexico’s second-largest manufacturing sector, according to Canifarma figures released earlier this month. The country’s 112 residents and annual sales of 2.5 billion units of pharmaceuticals make it a prime market for drug firms. Mexican pharmaceutical sales have increased more than 6% sequentially over the past few years and are projected to reach MXN 195.2 billion ($14 billion) in 2012. The country’s pharmaceutical exports are expected to be worth $1.2 billion this year, with 65% of exports staying in Latin America. The industry accounts for 1% of Mexico’s GDP, 7% of manufacturing GDP and 8%, or $1.52 billion, of the country’s annual foreign direct investment.
Source: Dow Jones